These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33913200)

  • 1. Contemporary Concise Review 2020: Interstitial lung disease.
    Teoh AKY; Corte TJ
    Respirology; 2021 Jun; 26(6):604-611. PubMed ID: 33913200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Concise Review 2021: Interstitial lung disease.
    McCarthy C; Keane MP
    Respirology; 2022 Jul; 27(7):539-548. PubMed ID: 35513341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic.
    Wong AW; Fidler L; Marcoux V; Johannson KA; Assayag D; Fisher JH; Hambly N; Kolb M; Morisset J; Shapera S; Ryerson CJ
    Chest; 2020 Sep; 158(3):1069-1078. PubMed ID: 32333929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-synthase syndrome associated with SARS-Cov-2 infection.
    Chen XY; Chen J; Zhi LJ; Long KL; Gao PY
    BMC Pulm Med; 2024 Apr; 24(1):179. PubMed ID: 38622599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Pneumonia Followed by Anti-signal Recognition Particle Antibody-positive Fibrosing Interstitial Lung Disease.
    Tateishi T; Shimada S; Yamana T; Iijima Y; Sakakibara R; Mitsumura T; Shibata S; Honda T; Shirai T; Okamoto T; Tamaoka M; Sasai T; Miyazaki Y
    Intern Med; 2023 May; 62(9):1323-1328. PubMed ID: 36754401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic.
    Shao C; Shi Y; Chen R; Liu X; Huang H; Zhao Y; Xu K; Chen K; Wang M; Xu Z
    J Med Virol; 2023 Sep; 95(9):e29098. PubMed ID: 37707416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Sequelae of COVID-19: Focus on Interstitial Lung Disease.
    Johnston J; Dorrian D; Linden D; Stanel SC; Rivera-Ortega P; Chaudhuri N
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [When COVID-19 encounters interstitial lung disease: challenges and management].
    Ren YH; Wang SY; Liu M; Guo YM; Dai HP
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Aug; 43(8):633-638. PubMed ID: 32198915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expert recommendations for the diagnosis and treatment of interstitial lung disease caused by novel coronavirus pneumonia].
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Oct; 43(10):827-833. PubMed ID: 32992435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD).
    Gagiannis D; Steinestel J; Hackenbroch C; Schreiner B; Hannemann M; Bloch W; Umathum VG; Gebauer N; Rother C; Stahl M; Witte HM; Steinestel K
    Front Immunol; 2020; 11():587517. PubMed ID: 33123171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities.
    George PM; Spagnolo P; Kreuter M; Altinisik G; Bonifazi M; Martinez FJ; Molyneaux PL; Renzoni EA; Richeldi L; Tomassetti S; Valenzuela C; Vancheri C; Varone F; Cottin V; Costabel U;
    Lancet Respir Med; 2020 Sep; 8(9):925-934. PubMed ID: 32890499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-COVID-19 interstitial lung disease presenting with profound hypoxemia: Report of three cases demonstrating a good response to high-dose corticosteroid therapy.
    Uemasu K; Yasuda Y; Hirayama Y; Arasawa S; Iwashima D; Takahashi KI
    J Infect Chemother; 2022 Feb; 28(2):321-325. PubMed ID: 34810106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.
    Myall KJ; Mukherjee B; Castanheira AM; Lam JL; Benedetti G; Mak SM; Preston R; Thillai M; Dewar A; Molyneaux PL; West AG
    Ann Am Thorac Soc; 2021 May; 18(5):799-806. PubMed ID: 33433263
    [No Abstract]   [Full Text] [Related]  

  • 14. Progressive fibrosing interstitial lung disease: treatable traits and therapeutic strategies.
    Wongkarnjana A; Scallan C; Kolb MRJ
    Curr Opin Pulm Med; 2020 Sep; 26(5):436-442. PubMed ID: 32657838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-COVID Interstitial Lung Disease - The Looming Epidemic.
    Singh AK; Kumar OP; Bansal P; Margekar SL; Aggarwal R; Ghotekar LR; Gupta A
    J Assoc Physicians India; 2021 Jul; 69(7):11-12. PubMed ID: 34431265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic.
    Guiot J; Henket M; Frix AN; Delvaux M; Denis A; Giltay L; Thys M; Gester F; Moutschen M; Corhay JL; Louis R;
    Respir Investig; 2020 Nov; 58(6):437-439. PubMed ID: 32978099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extended utility of antifibrotic therapy in progressive fibrosing interstitial lung disease.
    Sarkar P; Avram C; Chaudhuri N
    Expert Rev Respir Med; 2020 Oct; 14(10):1001-1008. PubMed ID: 32567402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and acute exacerbation of interstitial lung disease.
    Kondoh Y; Kataoka K; Ando M; Awaya Y; Ichikado K; Kataoka M; Komase Y; Mineshita M; Ohno Y; Okamoto H; Ooki T; Tasaka Y; Tomioka H; Suda T
    Respir Investig; 2021 Sep; 59(5):675-678. PubMed ID: 34272158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease - frontiers and horizons.
    Jee AS; Sahhar J; Youssef P; Bleasel J; Adelstein S; Nguyen M; Corte TJ
    Pharmacol Ther; 2019 Oct; 202():40-52. PubMed ID: 31153954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study.
    Miyashita K; Hozumi H; Furuhashi K; Nakatani E; Inoue Y; Yasui H; Suzuki Y; Karayama M; Enomoto N; Fujisawa T; Inui N; Ojima T; Suda T
    Respir Res; 2024 Feb; 25(1):95. PubMed ID: 38383463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.